Research access

IRB and protocol aware access requests. The honest broker reviews scope and minimum necessary variables, provisions a study workspace limited to the approved cohort, and issues study-specific identifiers. Researchers never see the enterprise identifier or the crosswalk.

Protocol	Title	Principal investigator	Department	IRB	Submitted	Status	Study identifiers
I-12345	Breast cancer treatment outcomes by receptor status	Dr. Elena Marsh	Breast Surgery	IRB-2026-0412	2026-10-21	Submitted
I-23456	Immunotherapy response in non-small cell lung cancer	Dr. Marcus Oyelaran	Thoracic Oncology	IRB-2026-0388	2026-10-09	Under review
I-34567	Colorectal cancer survival and treatment sequencing	Dr. Priya Raman	GI Oncology	IRB-2026-0301	2026-09-22	Provisioned	260
I-45678	Genomic markers in acute leukemia	Dr. Henrik Solberg	Hematologic Oncology	IRB-2026-0217	2026-08-12	Provisioned	187

Audit log

Time	Actor	Action	Object	Detail
2026-11-02 23:39	Conversion lead	Apply crosswalk fix	Conversion	49 exceptions resolved; 17 crosswalk entries added
2026-11-02 23:39	J. Whitcomb	Provision	I-34567	260 study identifiers generated (HMAC-SHA256, per-study key)
2026-09-03 09:30	J. Whitcomb	Provision	I-45678	Study identifiers generated; crosswalk stored in linkage service